BR0209276A - Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas - Google Patents

Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas

Info

Publication number
BR0209276A
BR0209276A BR0209276-0A BR0209276A BR0209276A BR 0209276 A BR0209276 A BR 0209276A BR 0209276 A BR0209276 A BR 0209276A BR 0209276 A BR0209276 A BR 0209276A
Authority
BR
Brazil
Prior art keywords
azithromycin
inflammatory diseases
preparation
treatment
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0209276-0A
Other languages
English (en)
Inventor
Ognjen Culic
Michael Parnham
Vesna Erakovic
Original Assignee
Pliva D D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva D D filed Critical Pliva D D
Publication of BR0209276A publication Critical patent/BR0209276A/pt
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DA AZITROMICINA PARA A PREPARAçãO DE UM MEDICAMENTO PARA TRATAMENTO DE DOENçAS INFLAMATóRIAS NãO INFECCIOSAS". A invenção se refere ao uso de 9-deoxo-9-diidro-9a-metil-9a-aza-9a-homoeritromicina A (nome genérico: azitromicina) na terapia de doenças inflamatórias não infecciosas dominadas por neutrófilos, a composições farmacêuticas contendo azitromicina para administração entérica ou parenteral e a processos para a produção dessas composições farmacêuticas.
BR0209276-0A 2001-04-27 2002-04-10 Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas Withdrawn BR0209276A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20010301A HRP20010301A2 (en) 2001-04-27 2001-04-27 New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
PCT/EP2002/003984 WO2002087596A2 (en) 2001-04-27 2002-04-10 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases

Publications (1)

Publication Number Publication Date
BR0209276A true BR0209276A (pt) 2004-06-15

Family

ID=10947306

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209276-0A Withdrawn BR0209276A (pt) 2001-04-27 2002-04-10 Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas

Country Status (19)

Country Link
US (1) US20050054587A1 (pt)
EP (1) EP1392327A2 (pt)
JP (1) JP2004531539A (pt)
CN (1) CN1582158A (pt)
AR (1) AR034223A1 (pt)
BG (1) BG108286A (pt)
BR (1) BR0209276A (pt)
CA (1) CA2443381A1 (pt)
CZ (1) CZ20032932A3 (pt)
EA (1) EA200301187A1 (pt)
HR (1) HRP20010301A2 (pt)
HU (1) HUP0303988A2 (pt)
IL (1) IL158236A0 (pt)
MX (1) MXPA03009849A (pt)
PL (1) PL364086A1 (pt)
SK (1) SK13352003A3 (pt)
WO (1) WO2002087596A2 (pt)
YU (1) YU84503A (pt)
ZA (1) ZA200308933B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0315671D0 (en) 2003-07-04 2003-08-13 Chelsea And Westminster Nhs Tr Improvements in or relating to organic compounds
EP1699456A1 (en) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
ATE529117T1 (de) 2004-07-02 2011-11-15 Wakamoto Pharma Co Ltd Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür
JP2008526945A (ja) * 2005-01-14 2008-07-24 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症活性を有する9a−カルバモイルおよびチオカルバモイルアザライド
US20060293261A1 (en) * 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. Clarithromycin or a salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli
US20080057129A1 (en) * 2006-04-03 2008-03-06 Lerner E I Drug microparticles
CN103193840A (zh) 2006-05-01 2013-07-10 大正制药株式会社 大环内酯衍生物
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
JP2011527709A (ja) * 2008-07-10 2011-11-04 インスパイアー ファーマシューティカルズ,インコーポレイティド 眼瞼炎の治療方法
WO2010062787A1 (en) 2008-11-03 2010-06-03 Washington University Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
WO2010085572A1 (en) * 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
ES2412059T3 (es) 2009-01-30 2013-07-10 Glaxo Group Limited Macrólido antiinflamatorio
US20130045939A1 (en) * 2010-03-19 2013-02-21 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
WO2017010382A1 (ja) * 2015-07-14 2017-01-19 国立大学法人大阪大学 筋強直性ジストロフィー治療薬
CN113209084A (zh) * 2021-05-18 2021-08-06 南开大学 化合物cp0119在制备用于治疗炎性肠病的药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
WO1995009601A1 (en) * 1993-10-01 1995-04-13 The Procter & Gamble Company Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
WO1995030422A1 (en) * 1994-05-06 1995-11-16 Pfizer Inc. Controlled-release dosage forms of azithromycin
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
ES2267549T3 (es) * 1999-06-29 2007-03-16 Sandoz Ag Procedimiento para la produccion de azitromicina.
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin

Also Published As

Publication number Publication date
MXPA03009849A (es) 2004-05-24
ZA200308933B (en) 2004-11-17
HUP0303988A2 (hu) 2004-04-28
EP1392327A2 (en) 2004-03-03
CZ20032932A3 (cs) 2004-08-18
HRP20010301A2 (en) 2001-12-31
CA2443381A1 (en) 2002-11-07
WO2002087596A3 (en) 2003-01-03
EA200301187A1 (ru) 2004-04-29
JP2004531539A (ja) 2004-10-14
BG108286A (bg) 2004-09-30
AR034223A1 (es) 2004-02-04
SK13352003A3 (en) 2004-10-05
YU84503A (sh) 2006-08-17
CN1582158A (zh) 2005-02-16
US20050054587A1 (en) 2005-03-10
PL364086A1 (en) 2004-12-13
IL158236A0 (en) 2004-05-12
WO2002087596A2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
BR0209276A (pt) Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas
TW200640499A (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
DE60315145D1 (de) Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
BR0211601A (pt) Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos
YU27203A (sh) Pirazol derivati za tretiranje virusnih oboljenja
HK1068606A1 (en) Novel aminobenzoephenones
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
MY159377A (en) Aqueous suspensions of ciclesonide for nebulisation
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
BR0210473A (pt) Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ID29025A (id) Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
BR0013723A (pt) Uso de bissulfonamidas, para produção de medicamentos para profilaxia ou tratamento de hiperlipidemia
WO2005048978A3 (en) A controlled release pharmaceutical composition and a process for preparing the same
BR0307703A (pt) Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.